Anti-inflammatory effect of β2-agonists: Inhibition of TNF-α release from human mast cells

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 6 I, 1997, Pages 825-831

  Bissonnette, Elyse Y ^a   Befus, A Dean ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Allergic reactions; Asthma; Histamine; Mast cells; TNF ; 2 agonist

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; ISOPRENALINE; LONG ACTING DRUG; PROPRANOLOL; SALBUTAMOL; SALMETEROL;

ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BETA ADRENERGIC STIMULATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; MAST CELL; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0031395199     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70280-X     Document Type: Article

References (54)

1. Page CP. Beta agonists and the asthma paradox. J Asthma 1993;30:155-64.
2. Erjefält I, Persson CGA. Pharmacologic control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 1991;143:1008-14.
3. Grönneberg R, Zetterström O. Inhibitory effects of formoterol and terbutaline on the development of late phase skin reactions. Clin Exp Allergy 1992;21:257-63.
4. Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995;152:838-60.
5. 4. J Pharmacol Exp Ther 1994;268:1339-43.
6. Busse WW, Sosman JM. Isoproterenol inhibition of isolated neutrophil function. J Allergy Clin Immunol 1984;73:404-10.
7. Didier M, Aussel C, Ferrua B, Fehlman M. Regulation of interleukin-2 synthesis by cAMP in human T cells. J Immunol 1987;139:1179-84.
8. Feldman RD. β-Adrenergic receptor-mediated suppression of interleukin-2 receptors in human lymphocytes. J Immunol 1987;139:3355-9.
9. Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987;90:421-9.
10. Butchers PR, Vardey CJ, Johnson M. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 1991;104:672-6.
11. Okayama Y, Church MK. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int Arch Allergy Immunol 1992;97:216-25.
12. Nials AT, Ball DI, Butchers PR, Coleman RA, Humbles AA, Johnson M, et al. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol. Eur J Pharmacol 1994;251:127-35.
13. Nilsson G, Schwartz LB. Mast-cell heterogeneity: structure and mediators. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. Oxford: Blackwell Scientific Publications; 1995. p. 195-208.
14. Redington AE, Polosa R, Walls AF, Howarth PH, Holgate ST. Role of mast cells and basophils in asthma. Chem Immunol 1995;62:22-59.
15. Borish L, Joseph BZ. Inflammation and the allergic response. Med Clin North Am 1992;76:765-87.
16. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989;170:245-57.
17. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
18. Arai K, Lee F, Miyajima A, Miyatake S, Aral N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 1990;59:783-836.
19. Ohno I, Ohkawara Y, Yamauchi K, Tanno Y, Takishima T. Production of tumor necrosis factor with IgE receptor triggering from sensitized lung tissue. Am J Respir Cell Mol Biol 1990;3:285-9.
20. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNFα-/cachectin. Nature 1990;346:274-6.
21. Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 1993;21:S447-63.
22. Cromwell O, Hamid Q, Corrigan CJ, Barkans J, Meng Q, Collins PD, et al. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor alpha. Immunology 1992;77:330-7.
23. Tosi MF, Stark JM, Smith CW, Hamedani A, Gruenert DC, Infeld MD. Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil-epithelial cell adhesion. Am J Respir Cell Mol Biol 1992;7:214-21.
24. Yamada N, Wakugawa M, Kuwata S, Yoshida T, Nakagawa H. Chronologic analysis of in situ cytokine expression in mite allergen-induced dermatitis in atopic subjects. J Allergy Clin Immunol 1995;96:1069-75.
25. Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995;152:76-80.
26. Kips JC, Tavernier JH, Joos GF, Peleman RA, Pauwels RA. The potential role of tumour necrosis factor α in asthma. Clin Exp Allergy 1993;23:247-50.
27. Seldon PM, Barnes PJ, Meja K, Giembycz MA. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Mol Pharmacol 1995;48:747-57.
28. Benyon RC, Bissonnette EY, Befus AD. Tumor necrosis factor-alpha dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies. J Immunol 1991;147:2253-8.
29. Shore PA, Burkhalter A, Cohn VH Jr. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959;127:182-6.
30. Bissonnette EY, Befus AD. Inhibition of mast cell-mediated cytotoxicity by IFN-α/β and -γ. J Immunol 1990;145:3385-90.
31. Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantification of natural killer activity. J Clin Immunol 1981;1:51-63.
32. Schleimer RP, Benenati SV, Friedman B, Bochner BS. Do cytokines play a role in leukocyte recruitment and activation in the lungs? Am Rev Respir Dis 1991;143:1169-74.
33. Bissonnette EY, Enciso JA, Befus AD. Inhibition of TNFα release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin Exp Immunol 1995;102:78-84.
34. Old LJ. Tumor necrosis factor (TNF). Science 1985;230:630-2.
35. Ohkawara Y, Yamauchi K, Tanno Y. Tamura G, Ohtani H, Nagura H, et al. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-α in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 1992;7:385-92.
36. 2-adrenergic agonists. J Immunol 1992;148:3441-5.
37. Sekut L, Champion BR, Page K, Menius JA Jr, Connolly KM. Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immunol 1995;99:461-6.
38. 2-adrenergic agonists in mouse ameboid microglial cells. Exp Brain Res 1991;86:407-13.
39. 2-agonist. Ann Pharmacother 1993;27:1478-87.
40. Whelan CJ, Johnson M, Vardey CJ. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br J Pharmacol 1993;110:613-8.
41. 2-adrenoceptor agonist in guinea pig skin. Eur J Pharmacol 1995;272:185-93.
42. 2-adrenoceptor agonist, salmeterol. Br J Pharmacol 1993;108:507-15.
43. Green SA, Spasoff AP, Coleman RA, Johnson M, Liggett SB. Sustained activation of a G protein-coupled receptor via 'anchored' agonist binding: molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J Biol Chem 1996;271:24029-35.
44. Hadcock JR, Wang H, Malbon CC. Agonist-induced destabilization of β-adrenergic receptor mRNA. J Biol Chem 1989;264:19928-33.
45. 2-adrenoceptor agonists. Trends Pharmacol Sci 1996;17:324-30.
46. Nishikawa M, Mak JCW, Shirasaki H, Harding SE, Barnes PJ. Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary β-adrenergic receptors in guinea pigs. Am J Respir Cell Mol Biol 1994;10:91-9.
47. Chong LK, Morice AH, Yeo WW, Schleimer RP, Peachell PT. Functional desensitization of β agonist responses in human lung mast cells. Am J Respir Cell Mol Biol 1995;13:540-6.
48. Pearce FL, Befus AD, Bienenstock J. Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J Allergy Clin Immunol 1984;73:819-23.
49. Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Fodinger D, et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med 1992;175:1353-65.
50. Foss HD, Herbst H, Araujo I, Hummel M, Berg E, Schmitt-Graff A, et al. Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadonepathy (Rosai-Dorfman disease). J Pathol 1996;179:60-5.
51. Benyon RC, Lowman MA, Rees PH, Holgate ST, Church MK. Mast cell heterogeneity. In: Asthma reviews, Vol. 2. Morley J, editor, London: Academic Press; 1989. p. 151-89.
52. Pearce FL, Befus AD, Gauldie J, Bienenstock J. Mucosal mast cells, II: effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. J Immunol 1982;128:2481-6.
53. 3 receptors. Am J Respir Cell Mol Biol 1996;14:620-6.
54. 2-agonists: greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1994;150:381-7.